Neometals Share Discussion Threads

[pc-49] 08/2/2006 18:59

(with reference to posts 7147-7152)

Swords are drawn, let the battle begin.
My money's on the Swede.
PC-49 sn

[pc4900074200] 08/2/2006 18:15

The 1,028,759 look to be F & C Management PLC.

That's what is listed for them on 21/1/2005.

pc

Out in one go. All 11.81%.

[25october1969] 08/2/2006 17:41

Look on the positive side - someone must have bought 2m shares

[davidrigby] 08/2/2006 17:29

the 2 trades just listed 2.028 million sells
some one thinks this is dead in the water

[wild bill] 08/2/2006 10:13

pack of three will be obtained and added to luggage - thanks for the advice

[waldron] 07/2/2006 12:33

enjoy


but do be careful

[wild bill] 07/2/2006 12:18

too many h's in when Marra

Frenchie, straight in and out - Val'dIsere

[pc4900074200] 07/2/2006 10:39

As was posted [across the road] we are now a cash shell.

It's now a waiting game.

Will a private company step in? [ZI failed]. Why?

Will our management try to buy into a profitable company?

If our products [patents running out] were of any use, would
Others not have snapped them up?

Needle-stick is moving on.

ZI wanted NMT but was rebuffed by them.

As was posted last week, another companies syringe on trial
with the NHS with what looks to be firm orders to follow.

Missed opportunities for NMT again!!

What were the reasons negotiations were terminated?

Offer to small?

No board positions for the NMT management?

[If they are not taking wages ATM]. They would want something
for their efforts?

Why were the shareholders not given the choice to know what
was placed on the table, then be able to make a choice to except
or reject the offer?

Many questions with no answers?

We have a management that are showing their shareholders no
Respect.

They may steer the ship but they do not own it!!

Before the EGM and board takeover we had something in place
to give us hope that this company could turn to profit.

We now have nothing and no prospect of anything for the future.

All the while, more shareholders sell and move on.

pc

[totana] 07/2/2006 10:25

Damn! I ate it when tat appens!

[waldron] 07/2/2006 10:19

let me know, if nearby.

[wild bill] 07/2/2006 10:09

Japanese food?

or Shush?

[waldron] 07/2/2006 09:52

very quiet

[wild bill] 07/2/2006 09:49

quiet in here

[pc4900074200] 02/2/2006 14:18

never in the field of medical technology
has so little been done
by so many (directors)
without communication
for so many (shareholders)
and at their (the PI's) expense

this year's award goes to

nominations on this thread please..........



pc

[wild bill] 02/2/2006 09:50

good toons here...............

[wild bill] 02/2/2006 09:41

"Give me just a little more time"

"Life's too short to make a mistake
Let's think of each other and hesitate........"

words are quite apt.

[goldengoose] 01/2/2006 18:13

An easy ride! At least until IKEA man or other, ousts him from his robbed gold empire.

[wild bill] 01/2/2006 11:02

"chief executive is rather grand a title for such a small firm"

And 'Chairman of the Board' is what?

[waldron] 01/2/2006 09:20

NMT chief quits after investor coup
JOHN BOWKER

NMT, the fallen Scottish biotech star, yesterday lost its chief executive just four months after a group of activist investors wrested control of the firm.

Graham Crowther, who had been allowed to remain at the company despite the ascendency of turnaround specialist Volvere, is believed to have jumped ship to a rival healthcare firm. He had previously been leading the attempt to secure customers and sales for NMT, but was yet to report any success.



Crowther had been on a 12-month contract, but as he opted to leave voluntarily he will not be entitled to a pay-off. His new employer is believed to specialise in female health products.

Volvere's Jonathan Lander - now a non-executive director at NMT - said: "We have been getting on well together these past few months, but he has got a good role at his new company and we wish him well."

He added that the position would not be filled, as "chief executive is rather grand a title for such a small firm". Volvere had already ousted the rest of the previous management for making money while the company did nothing, although Crowther had been investigating a potential partnership deal in the Far East.

Livingston-based NMT - a maker of syringes - had no customers and a £6.5m cash-pile when its was targeted by Volvere last year. The AIM-listed specialist won control following a closely fought vote in September.

NMT was forced to cut 200 manufacturing jobs two years ago after the commercial failure of its first syringe. It has been unsuccessfully targeted by fellow biotech Zi Medical as well as Volvere, while recent financial disclosures have unveiled Peter Gyllenhammar - the Swedish financier - as a stake-builder in the group.

This article:

Last updated: 01-Feb-06 02:24 GMT

[waldron] 01/2/2006 08:16

Re Alliance

RNS Number:7223X
International Medical Devices PLC
01 February 2006



International Medical Devices starts safe needle trials with NHS


International Medical Devices (IMD or 'the Company') is pleased to announce that
its range of safe needles and syringes is to undergo clinical tests with the
National Health Service with delivery of supplies into the NHS scheduled to
follow immediately. Marketing of the devices is being conducted by IMD's
wholly-owned subsidiary Meddis Ltd which is an existing approved supplier to the
NHS.

A number of retractable and novel safe devices are being tested. IMD is
confident that its products will meet the NHS's needs both in terms of quality,
clinical efficiency and price. Until now the cost of so-called safe devices has
been a prohibitive factor for health authorities but all products offered by IMD
will be at a small premium over conventional needles currently used and will
undercut existing devices from other manufacturers.

Needlestick accidents are the second biggest cause of injuries to health workers
in both the NHS and private sectors. There are 40,000 reported needlestick
accidents a year in the UK and it is thought as many again go unreported.

They account for 17 per cent of accidents to NHS staff. Contaminated needles can
transmit more than 20 dangerous blood-borne pathogens including hepatitis B and
C and HIV. According to the NHS at least four healthcare workers have died
following occupationally acquired HIV infection*. Recent cases, including one
brought by Unison against the Scottish NHS, have highlighted the need for the
widespread use of safe devices.

The NHS is keen to see widespread use of safety devices for all its "frontline"
staff before expected legislation is introduced to make safe needles
compulsory.

* The Management of Health, Safety and Welfare Issues. NHS 2005

About IMD:

International Medical Devices plc was founded to exploit opportunities in the
medical devices market, initially in the UK and Europe. It was admitted to AIM
on November 10, 2004 and in July it acquired a range of technology patents,
including those covering safe needles, from Eastland Technology Australia Ltd
and distribution rights from Eastland Medical Systems Ltd. In September the
Company acquired the entire share capital of Meddis Ltd, a distributor of acute
care medical devices.

www.imd-plc.com

Further information:

Chris Thomas, IMD: 0207 659 5216

Alan Frame, Westport Communications: 0207 405 7777 or 07850 944187





This information is provided by RNS
The company news service from the London Stock Exchange
END

SALUAONRNURAOAR

[waldron] 01/2/2006 08:11

LONDON (AFX) - International Medical Devices PLC said its range of safe needles and syringes is to undergo clinical tests with the National Health Service, with delivery of supplies into the NHS scheduled to follow immediately. [e-mail] tc


COPYRIGHT

[thekida] 31/1/2006 19:13

wild bill....how much cash have you blown on these?

TK